Borgatti P, Zauli G, Colamussi M L, Gibellini D, Previati M, Cantley L L, Capitani S
Institute of Human Anatomy, University of Ferrara, Italy.
Eur J Immunol. 1997 Nov;27(11):2805-11. doi: 10.1002/eji.1830271110.
The biological basis for the pleiotropic activity of extracellular human immunodeficiency virus (HIV)-1 Tat protein on lymphoid T cell survival is not well understood. We have here demonstrated that the addition in culture of 0.1-10 nM Tat protein to 36-h serum-starved lymphoblastoid Jurkat T cells rapidly stimulates the catalytic activity of phosphatidylinositol 3-kinase (PI 3-K). The peak of activation was observed 30 min after Tat addition. Extracellular Tat also stimulated the catalytic activity of the Akt/PKB kinase, a major target of PI 3-K lipid products. Pretreatment of serum-starved Jurkat cells with 100 nM wortmannin (WT) or 10 microM LY294002, two unrelated pharmacological inhibitors of PI 3-K, markedly suppressed the catalytic activity of both PI 3-K and Akt/PKB in Jurkat cells. Moreover, at low concentrations (0.1-1 nM), extracellular Tat showed a small but reproducible protection of Jurkat cells from apoptosis induced by serum deprivation (p < 0.05), while the combination of Tat plus 100 nM WT significantly (p < 0.05) increased the percentage of apoptosis with respect to cells left untreated or treated with Tat alone. Taken together, these data suggest that the anti-apoptotic activity of low concentrations of Tat protein on Jurkat cells is mediated by a PI 3-kinase/Akt pathway.
细胞外人类免疫缺陷病毒(HIV)-1反式激活蛋白(Tat)对淋巴T细胞存活的多效性活性的生物学基础尚未完全明确。我们在此证明,在培养中向饥饿血清36小时的淋巴母细胞性Jurkat T细胞添加0.1 - 10 nM的Tat蛋白可迅速刺激磷脂酰肌醇3激酶(PI 3-K)的催化活性。添加Tat后30分钟观察到激活峰值。细胞外Tat还刺激了Akt/PKB激酶的催化活性,Akt/PKB激酶是PI 3-K脂质产物的主要靶点。用100 nM渥曼青霉素(WT)或10 μM LY294002(两种不相关的PI 3-K药理学抑制剂)预处理饥饿血清的Jurkat细胞,可显著抑制Jurkat细胞中PI 3-K和Akt/PKB的催化活性。此外,在低浓度(0.1 - 1 nM)下,细胞外Tat对血清剥夺诱导的Jurkat细胞凋亡显示出轻微但可重复的保护作用(p < 0.05),而Tat加100 nM WT的组合相对于未处理或仅用Tat处理的细胞显著(p < 0.05)增加了凋亡百分比。综上所述,这些数据表明低浓度Tat蛋白对Jurkat细胞的抗凋亡活性是由PI 3激酶/Akt途径介导的。